Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Bleeding and Clotting Disorders Institute (BCDI) is a non-profit healthcare organization and federally recognized Hemophilia Treatment Center (HTC) based in Peoria, Illinois. It provides comprehensive, multi-disciplinary care for pediatric and adult patients with rare bleeding and clotting disorders, including hemophilia, von Willebrand disease, and various forms of thrombosis. BCDI integrates clinical treatment with an in-house specialized pharmacy and a robust clinical research department that participates in national and international trials for novel hematological therapies. The institute serves a large geographic area in downstate Illinois, focusing on improving patient outcomes through specialized expertise, education, and personalized care models. As a research-active site, BCDI contributes to the development of next-generation treatments, including extended half-life factors and gene therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bleeding and Clotting Disorders Institute.